A quantum leap for biology

A group of 8 people standing shoulder to shoulder, smiling.

(L-R) Adjunct Professor Christine Williams, Dr Alan Finkel AC FAA FTSE, The Honourable Gabrielle Upton, Dr Richard Johnson, Professor Warwick Bowen, Professor Halina Rubinsztein-Dunlop, Professor Deborah Terry AO, Rachael Birks.

3 September 2024

抖阴app官网 has launched a $45 million research initiative to position Australia as a global leader in quantum biotechnology, and tackle some of the world’s biggest challenges.

The brings together quantum technologies with life sciences, paving the way for advancements in health, energy and agriculture.

Led by from 抖阴app官网’s , QUBIC is a multi-disciplinary collaboration involving 5 Australian universities, industry and government partners.

“The aim is to revolutionise the technology available to biosciences and biotechnology,” Professor Bowen said.

“By applying quantum computing and sensing to cells, molecules and even the brain, QUBIC's research will transform our understanding of biology, from how enzymes trigger reactions to how viruses invade cells and how our brains function.”

QUBIC Deputy Director, , said the centre has the potential for real impact.

“We are leading global quantum biotechnology innovation and creating the quantum workforce of the future – a pipeline of qualified people to take advantage of this emerging field in biotechnology,” Professor Rubinsztein-Dunlop said.

By 2045, this field is expected to generate 50,000 jobs and contribute $9 billion to Australia’s economy.

QUIBIC Director of Technology, Distinguished Professor Dayong Jin said the research will bridge quantum and the biological sciences.

“By allowing us to observe biochemical pathways and detect early signs of disease, quantum biotechnology will transform our understanding of subcellular compartments,” Professor Jin said.

“This innovation will significantly boost Australia’s capabilities in biotechnology, diagnostics and manufacturing, making us more competitive on the global stage."

Professor Bowen said QUBIC’s research was well underway with a team of leading university researchers, industry and government partners and experts including CSIRO.

“I’m thrilled to be part of this diverse, multidisciplinary team, pioneering the field of quantum biotechnology and delivering real-world outcomes.”